Peripheral Transcutaneous Neuromodulation of the Post-tibial Nerve for Solifenacin 10 mg. Hyperactive Bladder Syndrome

NCT03468465 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
110
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia